Why is the Medibank (ASX:MPL) share price underperforming NIB (ASX:NHF) lately?

Medibank shares have been underperforming NIB.
The post Why is the Medibank (ASX:MPL) share price underperforming NIB (ASX:NHF) lately? appeared first on The Motley Fool Australia. –

The Medibank Private Limited (ASX: MPL) share price has been underperforming the NIB Holdings Limited (ASX: NHF) share price in recent weeks. What has been happening?

Over the last month, the Medibank share price is down by 3.3% whilst the NIB share price has fallen by less than 1%.

There is a much bigger difference over the last year, with Medibank shares up 29% compared to NIB shares going up by 57%.

Recent updates

Some of the biggest influences on the movement of businesses can be the updates they release.


For NIB, two of the most recent updates has been news from the ACCC and its FY21 result.

The ACCC has authorised Honeysuckle Health and NIB to form and operate a health services buying group. The Honeysuckle Health buying group intends to collectively negotiate and manage contracts with healthcare providers, including medical practitioners and hospitals, on behalf of NIB and other private health insurers and other healthcare payers (such as travel insurance companies) who join the group. However, this authorisation has been granted with a condition that major insurers Medibank, Bupa, HCF and HIF in WA are not allowed to join.

NIB’s FY21 result showed group underlying revenue increased 2.9% to $2.6 billion, whilst the claims expense rose 2.5% to $2 billion. Total group expenses fell 8.8% to $362.1 million. Group underlying operating profit increased 39.5% to $204.9 million, whilst net profit after tax (NPAT) rose by 84.5%.

NIB said that it was expecting similar market conditions in FY22 when compared to FY21. Australian resident health insurance net policyholder growth is expected for FY22 to be in the range of 2% to 3%. Growth in the New Zealand business is expected to be consistent with recent years.

The business has exposure to travel insurance. International travel is now seemingly on track to open sooner than previously expected.

It also said that, whilst it was a small step, its joint venture with Tasly allows it to have a licence to sell health insurance in China and it made its first sales in July. NIB called this opportunity over the long-term “considerable”.


Turning to updates from Medibank which could have influenced the Medibank share price in recent times.

The FY21 result was the latest major update from the biggest private health insurer. However, it didn’t demonstrate quite as much profit growth as NIB.

It said that revenue from external customers rose 2.1% to $6.9 billion, health insurance operating profit grew by 14.4% to $538.6 million and total underlying net profit rose by 8.5% to $398.7 million. The continuing operations net profit after tax went up 39.8% to $441.2 million.

Are either of the private health insurers opportunities?

Brokers aren’t convinced either of them are going to rise much over the next year.

For example, Morgans currently rates both the NIB share price and the Medibank share price as a hold.

Morgan’s price target for Medibank is $3.28, whilst the price target for NIB is $6.81. Based on those numbers, it implies that broker thinks that NIB shares will essentially be the same price in a year, but Medibank shares could fall by around 5%.

The post Why is the Medibank (ASX:MPL) share price underperforming NIB (ASX:NHF) lately? appeared first on The Motley Fool Australia.

Should you invest $1,000 in Medibank right now?

Before you consider Medibank, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Medibank wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Can the Medibank (ASX:MPL) share price hit $3.80 by the end of 2021?

Medibank (ASX:MPL) share price forecast for more growth: fund manager

ASX 200 company pays staff $1,500 to work from home

Medibank (ASX:MPL) share price lifts as staff vaccine mandate hits headlines

The most important catalyst for outperforming ASX shares: fund manager

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!